BioMarin Pharmaceutical

BioMarin Pharmaceutical is a global biotechnology company headquartered in San Rafael, California. Founded in 1997, the company employs 3,878 people and generates an annual revenue of $2.1 billion. BioMarin is dedicated to developing and commercializing targeted therapies for rare genetic diseases. The company focuses on addressing the root cause of these conditions, aiming to improve the lives of patients through innovative treatments. BioMarin's research and development efforts have resulted in eight first or best-in-class commercial treatments and a robust pipeline of product candidates. This pipeline continues to expand, applying the company's science-driven, patient-focused approach to a broader range of genetic disorders. BioMarin's commitment to patient well-being extends beyond its therapies. The company has issued a warning about potential recruitment fraud, urging job seekers to use only official BioMarin channels for employment inquiries. They emphasize that legitimate recruitment processes involve live interviews with BioMarin representatives and never require payments or fees from applicants. For more information about BioMarin Pharmaceutical and its career opportunities, please visit their website at biomarin.com.